247 related articles for article (PubMed ID: 26965518)
1. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
[TBL] [Abstract][Full Text] [Related]
2. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
Fallahi P; Ferrari SM; Antonelli A
Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
[TBL] [Abstract][Full Text] [Related]
3. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
4. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.
Fallahi P; Ferrari SM; Ruffilli I; Ragusa F; Biricotti M; Materazzi G; Miccoli P; Antonelli A
Expert Opin Drug Deliv; 2017 May; 14(5):647-655. PubMed ID: 27552635
[TBL] [Abstract][Full Text] [Related]
5. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
[TBL] [Abstract][Full Text] [Related]
6. TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.
Fallahi P; Ferrari SM; Camastra S; Politti U; Ruffilli I; Vita R; Navarra G; Benvenga S; Antonelli A
Obes Surg; 2017 Jan; 27(1):78-82. PubMed ID: 27272506
[TBL] [Abstract][Full Text] [Related]
7. In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.
Morini E; Catalano A; Lasco A; Morabito N; Benvenga S
Endocrine; 2019 Sep; 65(3):569-579. PubMed ID: 30919287
[TBL] [Abstract][Full Text] [Related]
8. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
[TBL] [Abstract][Full Text] [Related]
9. Tablet and oral liquid L-thyroxine formulation in the treatment of naïve hypothyroid patients with Helicobacter pylori infection.
Ribichini D; Fiorini G; Repaci A; Castelli V; Gatta L; Vaira D; Pasquali R
Endocrine; 2017 Sep; 57(3):394-401. PubMed ID: 27848196
[TBL] [Abstract][Full Text] [Related]
10. A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations.
Vita R; Saraceno G; Trimarchi F; Benvenga S
Endocrine; 2013 Feb; 43(1):154-60. PubMed ID: 22932947
[TBL] [Abstract][Full Text] [Related]
11. L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies.
Checchi S; Montanaro A; Pasqui L; Ciuoli C; De Palo V; Chiappetta MC; Pacini F
J Clin Endocrinol Metab; 2008 Feb; 93(2):465-9. PubMed ID: 18042648
[TBL] [Abstract][Full Text] [Related]
12. Utility of a Liquid Formulation of Levo-thyroxine in Differentiated Thyroid Cancer Patients.
Giusti M; Mortara L; Machello N; Monti E; Pera G; Marenzana M
Drug Res (Stuttg); 2015 Jun; 65(6):332-6. PubMed ID: 25020105
[TBL] [Abstract][Full Text] [Related]
13. Liquid L-thyroxine versus tablet L-thyroxine in patients on L- thyroxine replacement or suppressive therapy: a meta-analysis.
Laurent I; Tang S; Astère M; Wang KR; Deng S; Xiao L; Li QF
Endocrine; 2018 Jul; 61(1):28-35. PubMed ID: 29572710
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin C on the absorption of levothyroxine in patients with hypothyroidism and gastritis.
Jubiz W; Ramirez M
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1031-4. PubMed ID: 24601693
[TBL] [Abstract][Full Text] [Related]
15. [Bioequivalence of L-thyroxine tablets and a liquid L-thyroxine solution in the treatment of hypothyroid patients].
Grussendorf M; Vaupel R; Wegscheider K
Med Klin (Munich); 2004 Nov; 99(11):639-44. PubMed ID: 15583873
[TBL] [Abstract][Full Text] [Related]
16. Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation.
Morelli S; Reboldi G; Moretti S; Menicali E; Avenia N; Puxeddu E
Endocrine; 2016 Jun; 52(3):571-8. PubMed ID: 26537478
[TBL] [Abstract][Full Text] [Related]
17. Long term therapy with a new liquid L-thyroxine preparation: bioequivalence with L-T4 tablets.
Carpi A; Toni MG; Maccheroni M; De Gaudio C
Thyroidology; 1992 Dec; 4(3):115-9. PubMed ID: 1285037
[TBL] [Abstract][Full Text] [Related]
18. Oral liquid levothyroxine treatment at breakfast: a mistake?
Cappelli C; Pirola I; Gandossi E; Formenti A; Castellano M
Eur J Endocrinol; 2014 Jan; 170(1):95-9. PubMed ID: 24123095
[TBL] [Abstract][Full Text] [Related]
19. L-T4 Therapy in Enteric Malabsorptive Disorders.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Paparo SR; Antonelli A
Front Endocrinol (Lausanne); 2021; 12():626371. PubMed ID: 33708175
[TBL] [Abstract][Full Text] [Related]
20. Liquid and softgel capsules of l-thyroxine results lower serum thyrotropin levels more than tablet formulations in hypothyroid patients.
Benvenga S
J Clin Transl Endocrinol; 2019 Dec; 18():100204. PubMed ID: 31844631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
